SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-081537
Filing Date
2020-03-23
Accepted
2020-03-23 07:31:10
Documents
13
Period of Report
2020-03-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d851205d8k.htm   iXBRL 8-K 30175
2 EX-10.1 d851205dex101.htm EX-10.1 42597
  Complete submission text file 0001193125-20-081537.txt   204772

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA urgn-20200320.xsd EX-101.SCH 3065
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20200320_lab.xml EX-101.LAB 17375
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20200320_pre.xml EX-101.PRE 10950
8 EXTRACTED XBRL INSTANCE DOCUMENT d851205d8k_htm.xml XML 3232
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38079 | Film No.: 20733561
SIC: 2834 Pharmaceutical Preparations